CRESCENT BIOPHARMA INC (CBIO) Stock Cash Flow
NASDAQ:CBIO - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.24M | -8.24M | -87.93M | -56.20M | -55.20M | |||
| Depreciation Amortization | 14.00K | 230.00K | 290.00K | 100.00K | 100.00K | |||
| Change In Working Capital | -523.00K | -4.95M | 483.00K | -2.60M | 8.20M | |||
| Other non cash items | 31.37M | -20.14M | 3.40M | 3.60M | 3.20M | |||
| OPERATING CASH FLOW | -13.38M | -33.10M | -83.75M | -55.00M | -43.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -839.00K | -300.00K | -100.00K | |||
| Other Investing Activity | 5.26M | 55.43M | 49.03M | 9.90M | 27.50M | |||
| INVESTING CASH FLOW | 5.26M | 55.43M | 48.19M | 9.70M | 27.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 24.00K | 20.00K | 49.55M | 60.40M | 300.00K | |||
| Dividend Paid | -12.76M | -45.03M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -12.74M | -45.01M | 49.55M | 60.40M | 300.00K | |||
| CHANGE IN CASH | -20.86M | -22.68M | 13.99M | 15.10M | -15.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.38M | -33.10M | -83.75M | -55.00M | -43.60M | |||
| Capital Expenditure | N/A | 0.00 | -839.00K | -300.00K | -100.00K | |||
| FREE CASH FLOW | -13.38M | -33.10M | -84.59M | -55.30M | -43.70M | |||
All data in USD